Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Splashblocker is a private U.S. healthcare product company focused on reducing exposure to toilet plume aerosols in hospitals and other care settings. Its core commercial product, the SPLASHBLOCKER®, is a reusable, chemical-resistant barrier device placed over lidless institutional toilets to reduce aerosolized spread of infectious agents and hazardous drug residues during flushing. The company markets the product primarily as an engineering control for nurse, caregiver, patient, and visitor safety, especially in oncology and hazardous-drug handling environments. Splashblocker emphasizes evidence generation and workflow-friendly adoption, citing hospital studies and published occupational and environmental hygiene research supporting the device's effectiveness. The business appears to be a single-product commercial-stage medical safety company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Splashblocker.